Morphine Market Overview

Injection: Patients who are vomiting, unconscious, or in case of emergency, morphineis given by injection into a vein, into a muscle, or under the skin.

The global morphine market is expected to cross USD 23.08 Billion by 2030 at a CAGR of ~6.50%. Morphine is a narcotic and analgesic substance derived from opioids to treat severe pain, and it belongs to the class of drugs known as narcotic analgesics. Morphine increasespain tolerance.

On the other hand, the risk of morphine addiction is likely to hinder the growth of the global medical market over the forecast period. Morphine is an opioid and is thus a highly restricted substance. Opioid addiction is one of the biggest problems facing the developed world at present, but since opioids are the only naturally available painkillers known to man, their use is still rendered necessary. This has led to opioid addiction emerging as a serious threat to human wellbeing in the developed world over the last few decades. This is likely to lead to strict restrictions on the medical market, curtailing its growth.

Medical morphine is prescribed for conditions such as arthritis, cancer, and cardiovascular disorders. The increasing use of painkillers in combating these disorders is the main driver for the global medical Morphine Market. Cardiovascular disorders are among the deadliest diseases of the modern age, with the American Heart Association reporting that one in three deaths in the U.S. in 2014 was due to cardiovascular disorders. Cardiovascular diseases claimed over 800,000 lives in the U.S. in 2014, demonstrating their growing prevalence. As a result, medication to counter cardiovascular pain is becoming ever more prevalent. This is likely to be a major driver for the global medical market, as pollution and lifestyle factors are likely to further drive the prevalence of cardiovascular diseases across the world in the coming years.

Arthritis is also among the most common diseases among the elderly across the world, with more than 30 million in the U.S. alone suffering from osteoarthritis in 2015. Arthritis is an inflammatory condition manifested mainly through painful joints. As a result, painkillers are among the primary medications prescribed for arthritis treatment and management. This is likely to boost the global market over the forecast period, as medical morphine represents one of the most effective ways to counter arthritic pain currently available to medical science.

Regional Analysis

The global medical morphine market is geographically segmented into four major regions such as Americas, Asia Pacific, Europe, and the Middle East and Africa. The Americas account for the largest market share in the global medical morphine market owing to the increasing demand for opioid drugs as pain relievers. 

The Europe region accounts for the second largest market share in the market owing to the increasing prevalence of diseases like cancer, myocardial infarction and others. The medical market in the Asia Pacific region is projecting noteworthy growth due to the increasing geriatric population and rise in use of medical morphine as pain medication in this region.

The Middle East and Africa region is anticipated to project steady growth in the global medical market due to the limited availability of medical facilities, poor healthcare infrastructure, and lack of awareness among the population in underdeveloped areas of this region.

Market Segmentation

The report segments the global medical morphine market by route of administration, distribution channel, application, end use, and region.

By route of administration, the global medical morphine market is segmented into oral and injected medical morphine.

Based on distribution channel, market is divided into hospital pharmacy, retail pharmacy, online pharmacy, and others.

Based on application, market is segmented into cancer, arthritis, kidney stones, myocardial infarction, diarrhea, and others.

By end use, the market is segmented into home care, hospitals and clinics, and ambulatory surgical centers.

Key Players

Morphine Market players are Mallinckrodt Pharmaceuticals (Ireland), Alcaliber (Spain), Purdue Pharma (US), Sanofi Winthrop Industrie (France), Macfarlan Smith (UK), Sun Pharmaceutical Industries (India), Qinghai Pharmaceutical (China), Northeast Pharmaceutical Group (China), Pfizer Inc. (US), Verve Health Care Ltd. (India), Johnson Matthey Fine Chemicals (UK), Manus Aktteva Biopharma LLP (India), Mayne Pharma Group Limited (Australia), Daiichi Sankyo Inc. (Japan), and Taj Pharmaceuticals Limited (India) among others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com